Literature DB >> 21697498

APOBEC3 has not left an evolutionary footprint on the HIV-1 genome.

Diako Ebrahimi1, Firoz Anwar, Miles P Davenport.   

Abstract

It is known that the human immune proteins APOBEC3G and -F (hA3G/F) can inhibit Vif-deficient HIV by G-to-A mutation; however, the roles of these enzymes in the evolution of HIV are debated. We argue that if evolutionary pressure from hA3G/F exists there should be evidence of their imprint on the HIV genome in the form of (i) underrepresentation of hA3G/F target motifs (e.g., TGGG [targeted position is underlined]) and overrepresentation of product motifs (e.g., TAGG) and/or (ii) an increase in the ratio of nonsynonymous to synonymous (NS/S) G-to-A changes among hA3G/F target motifs and a decrease of NS/S A-to-G changes among hA3G/F product motifs. To test the first hypothesis, we studied the representation of hA3G/F target and product motifs in 1,932 complete HIV-1 genomes using Markov models. We found that the highly targeted motifs are not underrepresented and their product motifs are not overrepresented. To test the second hypothesis, we determined the NS/S G↔A changes among the hA3G/F target and product motifs in 1,540 complete sets of nine HIV-1 genes. The NS/S changes did not show an increasing/decreasing trend within the target/product motifs, but the NS/S changes within the motif AG was exceptionally low. We observed the same pattern by analyzing 740 human genes. Given that hA3G/F do not act on the human genome, this suggests a small NS/S change within AG has arisen by other mechanisms. We therefore find no evidence of an evolutionary footprint of hA3G/F. We postulate several mechanisms to explain why the HIV-1 genome does not contain the hA3G/F footprint.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697498      PMCID: PMC3165787          DOI: 10.1128/JVI.00658-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Inhibition of hepatitis B virus replication by APOBEC3G.

Authors:  Priscilla Turelli; Bastien Mangeat; Stephanie Jost; Sandrine Vianin; Didier Trono
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

2.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

3.  HIV mutation rate.

Authors:  M Nowak
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

4.  APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis.

Authors:  Holly A Sadler; Mark D Stenglein; Reuben S Harris; Louis M Mansky
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

5.  Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism.

Authors:  Rodolphe Suspène; Marie-Ming Aynaud; Denise Guétard; Michel Henry; Grace Eckhoff; Agnès Marchio; Pascal Pineau; Anne Dejean; Jean-Pierre Vartanian; Simon Wain-Hobson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-02       Impact factor: 11.205

6.  Mono- through hexanucleotide composition of the sense strand of yeast DNA: a Markov chain analysis.

Authors:  J Arnold; A J Cuticchia; D A Newsome; W W Jennings; R Ivarie
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

7.  Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.

Authors:  Corey B Moore; Mina John; Ian R James; Frank T Christiansen; Campbell S Witt; Simon A Mallal
Journal:  Science       Date:  2002-05-24       Impact factor: 47.728

8.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Mono- through hexanucleotide composition of the Escherichia coli genome: a Markov chain analysis.

Authors:  G J Phillips; J Arnold; R Ivarie
Journal:  Nucleic Acids Res       Date:  1987-03-25       Impact factor: 16.971

10.  Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses?

Authors:  S Karlin; W Doerfler; L R Cardon
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more
  17 in total

1.  Footprint of APOBEC3 on the genome of human retroelements.

Authors:  Firoz Anwar; Miles P Davenport; Diako Ebrahimi
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

Review 2.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

3.  Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels.

Authors:  Masako Nomaguchi; Naoya Doi; Yosuke Sakai; Hirotaka Ode; Yasumasa Iwatani; Takamasa Ueno; Yui Matsumoto; Yasuyuki Miyazaki; Takao Masuda; Akio Adachi
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

4.  Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.

Authors:  Brandy Verhalen; Gabriel J Starrett; Reuben S Harris; Mengxi Jiang
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

5.  Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.

Authors:  Andrew E Armitage; Koen Deforche; John J Welch; Kristel Van Laethem; Ricardo Camacho; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

6.  Back to the future: revisiting HIV-1 lethal mutagenesis.

Authors:  Michael J Dapp; Steven E Patterson; Louis M Mansky
Journal:  Trends Microbiol       Date:  2012-11-27       Impact factor: 17.079

7.  Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.

Authors:  Atsushi Koito; Terumasa Ikeda
Journal:  Front Microbiol       Date:  2013-02-20       Impact factor: 5.640

8.  APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon.

Authors:  Andrew E Armitage; Koen Deforche; Chih-Hao Chang; Edmund Wee; Beatrice Kramer; John J Welch; Jan Gerstoft; Lars Fugger; Andrew McMichael; Andrew Rambaut; Astrid K N Iversen
Journal:  PLoS Genet       Date:  2012-03-22       Impact factor: 5.917

Review 9.  Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.

Authors:  Carsten Münk; Björn-Erik O Jensen; Jörg Zielonka; Dieter Häussinger; Christel Kamp
Journal:  Viruses       Date:  2012-11-14       Impact factor: 5.048

10.  APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome.

Authors:  Diako Ebrahimi; Firoz Anwar; Miles P Davenport
Journal:  Retrovirology       Date:  2012-12-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.